According to the research report published by Market IntelliX, the global market for Structural Heart Disease Intervention Devices should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Structural Heart Disease Intervention Devices market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Structural Heart Disease Intervention Devices market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Atrial Interventional Class segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Congenital Heart Disease Treatment has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Structural Heart Disease Intervention Devices include Abbott Structural Heart, Philips, Japen Lifeline, Neovasc, Append Medical, Transverse Medical, Cardiomech, Thubrikar Aortic Valve Inc and Boston Scientific, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Structural heart disease intervention devices are medical devices used to treat heart diseases by repairing or replacing diseased or defective heart tissues or structures through minimally invasive procedures. Common types of structural heart disease intervention devices include:
Atrial septal defect closure devices: used to treat congenital heart defects by inserting a device into the heart through a catheter and placing a closure device over the defect to prevent blood from flowing from the left atrium to the right atrium.
Mitral valve repair devices: used to treat mitral valve regurgitation or prolapse by inserting a device into the heart through a catheter and placing a repair device over the damaged or prolapsed valve.
Transcatheter aortic valve replacement devices: used to treat aortic valve stenosis or regurgitation by inserting an artificial valve into the heart through a catheter and replacing the damaged aortic valve.
Cerebral aneurysm coiling devices: used to treat cerebral aneurysms or narrowing of the blood vessels in the brain by inserting a coil into the blood vessel through a catheter to strengthen the blood vessel and prevent blood from leaking out.
These structural heart disease intervention devices have been widely used in clinical practice and have achieved good treatment results, significantly improving the cardiovascular function of patients and enhancing their quality of life.
This report aims to provide a comprehensive study of the global market for Structural Heart Disease Intervention Devices. Report Highlights:
(1) Global Structural Heart Disease Intervention Devices market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Structural Heart Disease Intervention Devices market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Structural Heart Disease Intervention Devices market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Structural Heart Disease Intervention Devices segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Structural Heart Disease Intervention Devices segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Structural Heart Disease Intervention Devices, capacity, production and trends.
(7) Structural Heart Disease Intervention Devices industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Atrial Interventional Class
Cardiovascular Intervention
Market segment by application, can be divided into
Congenital Heart Disease Treatment
Valvular Heart Disease Treatment
Cardiomyopathy Treatment
Aneurysm and Arterial Valve Disease Treatment
Others
Market segment by players, this report covers
Abbott Structural Heart
Philips
Japen Lifeline
Neovasc
Append Medical
Transverse Medical
Cardiomech
Thubrikar Aortic Valve Inc
Boston Scientific
Edwards Lifesciences Corporation
Biomerics
LivaNova PLC
1 Market Overview
1.1 Structural Heart Disease Intervention Devices Definition
1.2 Global Structural Heart Disease Intervention Devices Market Size and Forecast
1.2.1 By Revenue, Global Structural Heart Disease Intervention Devices Market Size, 2018-2029
1.2.2 By Sales Volume, Global Structural Heart Disease Intervention Devices Market Size, 2018-2029
1.2.3 Global Structural Heart Disease Intervention Devices Price Trend, 2018-2029
1.3 China Structural Heart Disease Intervention Devices Market Size and Forecast
1.3.1 By Revenue, China Structural Heart Disease Intervention Devices Market Size, 2018-2029
1.3.2 By Sales Volume, China Structural Heart Disease Intervention Devices Market Size, 2018-2029
1.3.3 China Structural Heart Disease Intervention Devices Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Structural Heart Disease Intervention Devices Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China Structural Heart Disease Intervention Devices Share in Global Market, 2018-2029
1.4.3 Structural Heart Disease Intervention Devices Market Size: China VS Global, 2018-2029
1.5 Structural Heart Disease Intervention Devices Market Dynamics
1.5.1 Structural Heart Disease Intervention Devices Market Drivers
1.5.2 Structural Heart Disease Intervention Devices Market Restraints
1.5.3 Structural Heart Disease Intervention Devices Industry Trends
1.5.4 Structural Heart Disease Intervention Devices Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Structural Heart Disease Intervention Devices Revenue by Company, 2018-2023
2.2 Global Structural Heart Disease Intervention Devices Sales Volume by Company, 2018-2023
2.3 Global Structural Heart Disease Intervention Devices Price by Company, 2018-2023
2.4 Global Structural Heart Disease Intervention Devices Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Structural Heart Disease Intervention Devices Concentration Ratio
2.6 Global Structural Heart Disease Intervention Devices Mergers & Acquisitions, Expansion Plans
2.7 Global Structural Heart Disease Intervention Devices Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Structural Heart Disease Intervention Devices Revenue by Company, 2018-2023
3.2 China Structural Heart Disease Intervention Devices Sales Volume by Company, 2018-2023
3.3 China Structural Heart Disease Intervention Devices Structural Heart Disease Intervention Devices Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Structural Heart Disease Intervention Devices Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, Structural Heart Disease Intervention Devices Domestic VS Export
3.6 China Market, Structural Heart Disease Intervention Devices Import & Export
3.6.1 China Market, Structural Heart Disease Intervention Devices Import & Export, 2018-2029
3.6.2 China Structural Heart Disease Intervention Devices Import & Export Trends
3.6.3 Main Sources of China Structural Heart Disease Intervention Devices Import
3.6.4 Export Destination of China Structural Heart Disease Intervention Devices
4 Structural Heart Disease Intervention Devices Production by Region
4.1 Global Structural Heart Disease Intervention Devices Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of Structural Heart Disease Intervention Devices Manufacturers
4.3 Global Major Manufacturers, Structural Heart Disease Intervention Devices Capacity Expansion and Future Plans
4.4 Global Structural Heart Disease Intervention Devices Capacity by Region
4.5 Global Structural Heart Disease Intervention Devices Production by Region
4.5.1 Global Structural Heart Disease Intervention Devices Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global Structural Heart Disease Intervention Devices Production by Region, 2018-2023
4.5.3 Global Structural Heart Disease Intervention Devices Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Structural Heart Disease Intervention Devices Industry Chain
5.2 Structural Heart Disease Intervention Devices Upstream Analysis
5.2.1 Structural Heart Disease Intervention Devices Core Raw Materials
5.2.2 Main Manufacturers of Structural Heart Disease Intervention Devices Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Structural Heart Disease Intervention Devices Production Mode
5.6 Structural Heart Disease Intervention Devices Procurement Model
5.7 Structural Heart Disease Intervention Devices Industry Sales Model and Sales Channels
5.7.1 Structural Heart Disease Intervention Devices Sales Model
5.7.2 Structural Heart Disease Intervention Devices Typical Distributors
6 Sights by Type
6.1 Structural Heart Disease Intervention Devices Classification
6.1.1 Atrial Interventional Class
6.1.2 Cardiovascular Intervention
6.2 By Type, Global Structural Heart Disease Intervention Devices Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Structural Heart Disease Intervention Devices Revenue, 2018-2029
6.4 By Type, Global Structural Heart Disease Intervention Devices Sales Volume, 2018-2029
6.5 By Type, Global Structural Heart Disease Intervention Devices Price, 2018-2029
7 Sights by Application
7.1 Structural Heart Disease Intervention Devices Segment by Application
7.1.1 Congenital Heart Disease Treatment
7.1.2 Valvular Heart Disease Treatment
7.1.3 Cardiomyopathy Treatment
7.1.4 Aneurysm and Arterial Valve Disease Treatment
7.1.5 Others
7.2 By Application, Global Structural Heart Disease Intervention Devices Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Structural Heart Disease Intervention Devices Revenue, 2018-2029
7.4 By Application, Global Structural Heart Disease Intervention Devices Sales Volume, 2018-2029
7.5 By Application, Global Structural Heart Disease Intervention Devices Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Structural Heart Disease Intervention Devices Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global Structural Heart Disease Intervention Devices Revenue, 2018-2029
8.3 By Region, Global Structural Heart Disease Intervention Devices Sales Volume, 2018-2029
8.4 North America
8.4.1 North America Structural Heart Disease Intervention Devices Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America Structural Heart Disease Intervention Devices Market Size Market Share
8.5 Europe
8.5.1 Europe Structural Heart Disease Intervention Devices Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Structural Heart Disease Intervention Devices Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Structural Heart Disease Intervention Devices Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Structural Heart Disease Intervention Devices Market Size Market Share
8.7 South America
8.7.1 South America Structural Heart Disease Intervention Devices Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Structural Heart Disease Intervention Devices Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Structural Heart Disease Intervention Devices Market Size & CAGR,2018 VS 2022 VS 2029
9.2 By Country, Global Structural Heart Disease Intervention Devices Revenue, 2018-2029
9.3 By Country, Global Structural Heart Disease Intervention Devices Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. Structural Heart Disease Intervention Devices Market Size, 2018-2029
9.4.2 By Company, U.S. Structural Heart Disease Intervention Devices Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Structural Heart Disease Intervention Devices Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Structural Heart Disease Intervention Devices Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Structural Heart Disease Intervention Devices Market Size, 2018-2029
9.5.2 By Company, Europe Structural Heart Disease Intervention Devices Sales Volume Market Share, 2022
9.5.3 By Type, Europe Structural Heart Disease Intervention Devices Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Structural Heart Disease Intervention Devices Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Structural Heart Disease Intervention Devices Market Size, 2018-2029
9.6.2 By Company, China Structural Heart Disease Intervention Devices Sales Volume Market Share, 2022
9.6.3 By Type, China Structural Heart Disease Intervention Devices Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Structural Heart Disease Intervention Devices Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Structural Heart Disease Intervention Devices Market Size, 2018-2029
9.7.2 By Company, Japan Structural Heart Disease Intervention Devices Sales Volume Market Share, 2022
9.7.3 By Type, Japan Structural Heart Disease Intervention Devices Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Structural Heart Disease Intervention Devices Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Structural Heart Disease Intervention Devices Market Size, 2018-2029
9.8.2 By Company, South Korea Structural Heart Disease Intervention Devices Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Structural Heart Disease Intervention Devices Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Structural Heart Disease Intervention Devices Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Structural Heart Disease Intervention Devices Market Size, 2018-2029
9.9.2 By Company, Southeast Asia Structural Heart Disease Intervention Devices Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Structural Heart Disease Intervention Devices Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Structural Heart Disease Intervention Devices Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Structural Heart Disease Intervention Devices Market Size, 2018-2029
9.10.2 By Company, India Structural Heart Disease Intervention Devices Sales Volume Market Share, 2022
9.10.3 By Type, India Structural Heart Disease Intervention Devices Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Structural Heart Disease Intervention Devices Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Structural Heart Disease Intervention Devices Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia Structural Heart Disease Intervention Devices Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Structural Heart Disease Intervention Devices Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Structural Heart Disease Intervention Devices Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Abbott Structural Heart
10.1.1 Abbott Structural Heart Company Information, Head Office, Market Area and Industry Position
10.1.2 Abbott Structural Heart Structural Heart Disease Intervention Devices Models, Specifications and Application
10.1.3 Abbott Structural Heart Structural Heart Disease Intervention Devices Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Abbott Structural Heart Company Profile and Main Business
10.1.5 Abbott Structural Heart Recent Developments
10.2 Philips
10.2.1 Philips Company Information, Head Office, Market Area and Industry Position
10.2.2 Philips Structural Heart Disease Intervention Devices Models, Specifications and Application
10.2.3 Philips Structural Heart Disease Intervention Devices Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Philips Company Profile and Main Business
10.2.5 Philips Recent Developments
10.3 Japen Lifeline
10.3.1 Japen Lifeline Company Information, Head Office, Market Area and Industry Position
10.3.2 Japen Lifeline Structural Heart Disease Intervention Devices Models, Specifications and Application
10.3.3 Japen Lifeline Structural Heart Disease Intervention Devices Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Japen Lifeline Company Profile and Main Business
10.3.5 Japen Lifeline Recent Developments
10.4 Neovasc
10.4.1 Neovasc Company Information, Head Office, Market Area and Industry Position
10.4.2 Neovasc Structural Heart Disease Intervention Devices Models, Specifications and Application
10.4.3 Neovasc Structural Heart Disease Intervention Devices Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Neovasc Company Profile and Main Business
10.4.5 Neovasc Recent Developments
10.5 Append Medical
10.5.1 Append Medical Company Information, Head Office, Market Area and Industry Position
10.5.2 Append Medical Structural Heart Disease Intervention Devices Models, Specifications and Application
10.5.3 Append Medical Structural Heart Disease Intervention Devices Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Append Medical Company Profile and Main Business
10.5.5 Append Medical Recent Developments
10.6 Transverse Medical
10.6.1 Transverse Medical Company Information, Head Office, Market Area and Industry Position
10.6.2 Transverse Medical Structural Heart Disease Intervention Devices Models, Specifications and Application
10.6.3 Transverse Medical Structural Heart Disease Intervention Devices Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Transverse Medical Company Profile and Main Business
10.6.5 Transverse Medical Recent Developments
10.7 Cardiomech
10.7.1 Cardiomech Company Information, Head Office, Market Area and Industry Position
10.7.2 Cardiomech Structural Heart Disease Intervention Devices Models, Specifications and Application
10.7.3 Cardiomech Structural Heart Disease Intervention Devices Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Cardiomech Company Profile and Main Business
10.7.5 Cardiomech Recent Developments
10.8 Thubrikar Aortic Valve Inc
10.8.1 Thubrikar Aortic Valve Inc Company Information, Head Office, Market Area and Industry Position
10.8.2 Thubrikar Aortic Valve Inc Structural Heart Disease Intervention Devices Models, Specifications and Application
10.8.3 Thubrikar Aortic Valve Inc Structural Heart Disease Intervention Devices Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Thubrikar Aortic Valve Inc Company Profile and Main Business
10.8.5 Thubrikar Aortic Valve Inc Recent Developments
10.9 Boston Scientific
10.9.1 Boston Scientific Company Information, Head Office, Market Area and Industry Position
10.9.2 Boston Scientific Structural Heart Disease Intervention Devices Models, Specifications and Application
10.9.3 Boston Scientific Structural Heart Disease Intervention Devices Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Boston Scientific Company Profile and Main Business
10.9.5 Boston Scientific Recent Developments
10.10 Edwards Lifesciences Corporation
10.10.1 Edwards Lifesciences Corporation Company Information, Head Office, Market Area and Industry Position
10.10.2 Edwards Lifesciences Corporation Structural Heart Disease Intervention Devices Models, Specifications and Application
10.10.3 Edwards Lifesciences Corporation Structural Heart Disease Intervention Devices Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Edwards Lifesciences Corporation Company Profile and Main Business
10.10.5 Edwards Lifesciences Corporation Recent Developments
10.11 Biomerics
10.11.1 Biomerics Company Information, Head Office, Market Area and Industry Position
10.11.2 Biomerics Structural Heart Disease Intervention Devices Models, Specifications and Application
10.11.3 Biomerics Structural Heart Disease Intervention Devices Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Biomerics Company Profile and Main Business
10.11.5 Biomerics Recent Developments
10.12 LivaNova PLC
10.12.1 LivaNova PLC Company Information, Head Office, Market Area and Industry Position
10.12.2 LivaNova PLC Structural Heart Disease Intervention Devices Models, Specifications and Application
10.12.3 LivaNova PLC Structural Heart Disease Intervention Devices Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.12.4 LivaNova PLC Company Profile and Main Business
10.12.5 LivaNova PLC Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Structural Heart Disease Intervention Devices Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Structural Heart Disease Intervention Devices Market Restraints
Table 3. Structural Heart Disease Intervention Devices Market Trends
Table 4. Structural Heart Disease Intervention Devices Industry Policy
Table 5. Global Structural Heart Disease Intervention Devices Revenue by Company, 2018-2023, US$ million
Table 6. Global Structural Heart Disease Intervention Devices Revenue Market Share by Company, 2018-2023
Table 7. Global Structural Heart Disease Intervention Devices Sales Volume by Company, 2018-2023, (K Units)
Table 8. Global Structural Heart Disease Intervention Devices Sales Volume Market Share by Company, 2018-2023
Table 9. Global Structural Heart Disease Intervention Devices Price by Company, 2018-2023, (US$/Unit)
Table 10. Global Structural Heart Disease Intervention Devices Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Structural Heart Disease Intervention Devices Mergers & Acquisitions, Expansion Plans
Table 12. Global Structural Heart Disease Intervention Devices Manufacturers Product Type
Table 13. China Structural Heart Disease Intervention Devices Revenue by Company, 2018-2023, US$ million
Table 14. China Structural Heart Disease Intervention Devices Revenue Market Share by Company, 2018-2023
Table 15. China Structural Heart Disease Intervention Devices Sales Volume by Company, 2018-2023, (K Units)
Table 16. China Structural Heart Disease Intervention Devices Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, Structural Heart Disease Intervention Devices Production, Sales, Import and Export, 2018-2029, (K Units)
Table 18. China Structural Heart Disease Intervention Devices Import & Export Trends
Table 19. Main Sources of China Structural Heart Disease Intervention Devices Import
Table 20. Export Destination of China Structural Heart Disease Intervention Devices
Table 21. Global Headquarters and Manufacturing Base of Structural Heart Disease Intervention Devices Manufacturers
Table 22. Global Major Manufacturers, Structural Heart Disease Intervention Devices Capacity Expansion and Future Plans
Table 23. Global Structural Heart Disease Intervention Devices Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 24. Global Structural Heart Disease Intervention Devices Production by Region, 2018-2023, (K Units)
Table 25. Global Structural Heart Disease Intervention Devices Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of Structural Heart Disease Intervention Devices Upstream (Raw Materials)
Table 27. Global Structural Heart Disease Intervention Devices Typical Customers
Table 28. Structural Heart Disease Intervention Devices Typical Distributors
Table 29. By Type, Global Structural Heart Disease Intervention Devices Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global Structural Heart Disease Intervention Devices Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global Structural Heart Disease Intervention Devices Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global Structural Heart Disease Intervention Devices Revenue, 2018-2029, US$ Million
Table 33. By Region, Global Structural Heart Disease Intervention Devices Sales Volume, 2018-2029, (K Units)
Table 34. By Country, Global Structural Heart Disease Intervention Devices Revenue & CAGR,2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global Structural Heart Disease Intervention Devices Revenue, 2018-2029, US$ Million
Table 36. By Country, Global Structural Heart Disease Intervention Devices Revenue Market Share, 2018-2029
Table 37. By Country, Global Structural Heart Disease Intervention Devices Sales Volume, 2018-2029, (K Units)
Table 38. By Country, Global Structural Heart Disease Intervention Devices Sales Volume Market Share, 2018-2029
Table 39. Abbott Structural Heart Company Information, Head Office, Market Area and Industry Position
Table 40. Abbott Structural Heart Structural Heart Disease Intervention Devices Models, Specifications and Application
Table 41. Abbott Structural Heart Structural Heart Disease Intervention Devices Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Abbott Structural Heart Company Profile and Main Business
Table 43. Abbott Structural Heart Recent Developments
Table 44. Philips Company Information, Head Office, Market Area and Industry Position
Table 45. Philips Structural Heart Disease Intervention Devices Models, Specifications and Application
Table 46. Philips Structural Heart Disease Intervention Devices Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Philips Company Profile and Main Business
Table 48. Philips Recent Developments
Table 49. Japen Lifeline Company Information, Head Office, Market Area and Industry Position
Table 50. Japen Lifeline Structural Heart Disease Intervention Devices Models, Specifications and Application
Table 51. Japen Lifeline Structural Heart Disease Intervention Devices Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Japen Lifeline Company Profile and Main Business
Table 53. Japen Lifeline Recent Developments
Table 54. Neovasc Company Information, Head Office, Market Area and Industry Position
Table 55. Neovasc Structural Heart Disease Intervention Devices Models, Specifications and Application
Table 56. Neovasc Structural Heart Disease Intervention Devices Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Neovasc Company Profile and Main Business
Table 58. Neovasc Recent Developments
Table 59. Append Medical Company Information, Head Office, Market Area and Industry Position
Table 60. Append Medical Structural Heart Disease Intervention Devices Models, Specifications and Application
Table 61. Append Medical Structural Heart Disease Intervention Devices Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Append Medical Company Profile and Main Business
Table 63. Append Medical Recent Developments
Table 64. Transverse Medical Company Information, Head Office, Market Area and Industry Position
Table 65. Transverse Medical Structural Heart Disease Intervention Devices Models, Specifications and Application
Table 66. Transverse Medical Structural Heart Disease Intervention Devices Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Transverse Medical Company Profile and Main Business
Table 68. Transverse Medical Recent Developments
Table 69. Cardiomech Company Information, Head Office, Market Area and Industry Position
Table 70. Cardiomech Structural Heart Disease Intervention Devices Models, Specifications and Application
Table 71. Cardiomech Structural Heart Disease Intervention Devices Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Cardiomech Company Profile and Main Business
Table 73. Cardiomech Recent Developments
Table 74. Thubrikar Aortic Valve Inc Company Information, Head Office, Market Area and Industry Position
Table 75. Thubrikar Aortic Valve Inc Structural Heart Disease Intervention Devices Models, Specifications and Application
Table 76. Thubrikar Aortic Valve Inc Structural Heart Disease Intervention Devices Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Thubrikar Aortic Valve Inc Company Profile and Main Business
Table 78. Thubrikar Aortic Valve Inc Recent Developments
Table 79. Boston Scientific Company Information, Head Office, Market Area and Industry Position
Table 80. Boston Scientific Structural Heart Disease Intervention Devices Models, Specifications and Application
Table 81. Boston Scientific Structural Heart Disease Intervention Devices Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Boston Scientific Company Profile and Main Business
Table 83. Boston Scientific Recent Developments
Table 84. Edwards Lifesciences Corporation Company Information, Head Office, Market Area and Industry Position
Table 85. Edwards Lifesciences Corporation Structural Heart Disease Intervention Devices Models, Specifications and Application
Table 86. Edwards Lifesciences Corporation Structural Heart Disease Intervention Devices Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Edwards Lifesciences Corporation Company Profile and Main Business
Table 88. Edwards Lifesciences Corporation Recent Developments
Table 89. Biomerics Company Information, Head Office, Market Area and Industry Position
Table 90. Biomerics Structural Heart Disease Intervention Devices Models, Specifications and Application
Table 91. Biomerics Structural Heart Disease Intervention Devices Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Biomerics Company Profile and Main Business
Table 93. Biomerics Recent Developments
Table 94. LivaNova PLC Company Information, Head Office, Market Area and Industry Position
Table 95. LivaNova PLC Structural Heart Disease Intervention Devices Models, Specifications and Application
Table 96. LivaNova PLC Structural Heart Disease Intervention Devices Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. LivaNova PLC Company Profile and Main Business
Table 98. LivaNova PLC Recent Developments
List of Figure
Figure 1. Structural Heart Disease Intervention Devices Picture
Figure 2. By Revenue, Global Structural Heart Disease Intervention Devices Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global Structural Heart Disease Intervention Devices Market Size and Forecast, 2018-2029, (K Units)
Figure 4. Global Structural Heart Disease Intervention Devices Price Trend, 2018-2029, (US$/Unit)
Figure 5. By Revenue, China Structural Heart Disease Intervention Devices Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China Structural Heart Disease Intervention Devices Market Size and Forecast, 2018-2029, (K Units)
Figure 7. China Structural Heart Disease Intervention Devices Price Trend, 2018-2029 (US$/Unit)
Figure 8. By Revenue, China Structural Heart Disease Intervention Devices Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China Structural Heart Disease Intervention Devices Share of Global Market, 2018-2029
Figure 10. Global Structural Heart Disease Intervention Devices Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Structural Heart Disease Intervention Devices Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Structural Heart Disease Intervention Devices Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Structural Heart Disease Intervention Devices Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Structural Heart Disease Intervention Devices Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of Structural Heart Disease Intervention Devices Domestic VS Export, 2022
Figure 16. Global Structural Heart Disease Intervention Devices Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global Structural Heart Disease Intervention Devices Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Structural Heart Disease Intervention Devices Production Market Share & Forecast by Region, 2018-2029
Figure 19. Structural Heart Disease Intervention Devices Industry Chain
Figure 20. Structural Heart Disease Intervention Devices Procurement Model
Figure 21. Structural Heart Disease Intervention Devices Sales Model
Figure 22. Structural Heart Disease Intervention Devices Sales Channels, Direct Sales and Distribution
Figure 23. Atrial Interventional Class
Figure 24. Cardiovascular Intervention
Figure 25. By Type, Global Structural Heart Disease Intervention Devices Revenue, 2018-2029, US$ Million
Figure 26. By Type, Global Structural Heart Disease Intervention Devices Revenue Market Share, 2018-2029
Figure 27. By Type, Global Structural Heart Disease Intervention Devices Sales Volume, 2018-2029, (K Units)
Figure 28. By Type, Global Structural Heart Disease Intervention Devices Sales Volume Market Share, 2018-2029
Figure 29. By Type, Global Structural Heart Disease Intervention Devices Price, 2018-2029, (US$/Unit)
Figure 30. Congenital Heart Disease Treatment
Figure 31. Valvular Heart Disease Treatment
Figure 32. Cardiomyopathy Treatment
Figure 33. Aneurysm and Arterial Valve Disease Treatment
Figure 34. Others
Figure 35. By Application, Global Structural Heart Disease Intervention Devices Revenue, 2018-2029, US$ Million
Figure 36. By Application, Global Structural Heart Disease Intervention Devices Revenue Market Share, 2018-2029
Figure 37. By Application, Global Structural Heart Disease Intervention Devices Sales Volume, 2018-2029, (K Units)
Figure 38. By Application, Global Structural Heart Disease Intervention Devices Sales Volume Market Share, 2018-2029
Figure 39. By Application, Global Structural Heart Disease Intervention Devices Price, 2018-2029, (US$/Unit)
Figure 40. By Region, Global Structural Heart Disease Intervention Devices Revenue Market Share, 2018-2029
Figure 41. By Region, Global Structural Heart Disease Intervention Devices Sales Volume Market Share, 2018-2029
Figure 42. North America Structural Heart Disease Intervention Devices Revenue & Forecasts, 2018-2029, US$ Million
Figure 43. By Country, North America Structural Heart Disease Intervention Devices Revenue Market Share, 2022
Figure 44. Europe Structural Heart Disease Intervention Devices Revenue & Forecasts, 2018-2029, US$ Million
Figure 45. By Country, Europe Structural Heart Disease Intervention Devices Revenue Market Share, 2022
Figure 46. Asia Pacific Structural Heart Disease Intervention Devices Revenue & Forecasts, 2018-2029, US$ Million
Figure 47. By Country/Region, Asia Pacific Structural Heart Disease Intervention Devices Revenue Market Share, 2022
Figure 48. South America Structural Heart Disease Intervention Devices Revenue & Forecasts, 2018-2029, US$ Million
Figure 49. By Country, South America Structural Heart Disease Intervention Devices Revenue Market Share, 2022
Figure 50. Middle East & Africa Structural Heart Disease Intervention Devices Revenue & Forecasts, 2018-2029, US$ Million
Figure 51. U.S. Structural Heart Disease Intervention Devices Sales Volume, 2018-2029, (K Units)
Figure 52. By Company, U.S. Structural Heart Disease Intervention Devices Market Share, 2022
Figure 53. By Type, U.S. Structural Heart Disease Intervention Devices Sales Volume Market Share, 2022 VS 2029
Figure 54. By Application, U.S. Structural Heart Disease Intervention Devices Sales Volume Market Share, 2022 VS 2029
Figure 55. Europe Structural Heart Disease Intervention Devices Sales Volume, 2018-2029, (K Units)
Figure 56. By Company, Europe Structural Heart Disease Intervention Devices Market Share, 2022
Figure 57. By Type, Europe Structural Heart Disease Intervention Devices Sales Volume Market Share, 2022 VS 2029
Figure 58. By Application, Europe Structural Heart Disease Intervention Devices Sales Volume Market Share, 2022 VS 2029
Figure 59. China Structural Heart Disease Intervention Devices Sales Volume, 2018-2029, (K Units)
Figure 60. By Company, China Structural Heart Disease Intervention Devices Market Share, 2022
Figure 61. By Type, China Structural Heart Disease Intervention Devices Sales Volume Market Share, 2022 VS 2029
Figure 62. By Application, China Structural Heart Disease Intervention Devices Sales Volume Market Share, 2022 VS 2029
Figure 63. Japan Structural Heart Disease Intervention Devices Sales Volume, 2018-2029, (K Units)
Figure 64. By Company, Japan Structural Heart Disease Intervention Devices Market Share, 2022
Figure 65. By Type, Japan Structural Heart Disease Intervention Devices Sales Volume Market Share, 2022 VS 2029
Figure 66. By Application, Japan Structural Heart Disease Intervention Devices Sales Volume Market Share, 2022 VS 2029
Figure 67. South Korea Structural Heart Disease Intervention Devices Sales Volume, 2018-2029, (K Units)
Figure 68. By Company, South Korea Structural Heart Disease Intervention Devices Market Share, 2022
Figure 69. By Type, South Korea Structural Heart Disease Intervention Devices Sales Volume Market Share, 2022 VS 2029
Figure 70. By Application, South Korea Structural Heart Disease Intervention Devices Sales Volume Market Share, 2022 VS 2029
Figure 71. Southeast Asia Structural Heart Disease Intervention Devices Sales Volume, 2018-2029, (K Units)
Figure 72. By Company, Southeast Asia Structural Heart Disease Intervention Devices Market Share, 2022
Figure 73. By Type, Southeast Asia Structural Heart Disease Intervention Devices Sales Volume Market Share, 2022 VS 2029
Figure 74. By Application, Southeast Asia Structural Heart Disease Intervention Devices Sales Volume Market Share, 2022 VS 2029
Figure 75. India Structural Heart Disease Intervention Devices Sales Volume, 2018-2029, (K Units)
Figure 76. By Company, India Structural Heart Disease Intervention Devices Market Share, 2022
Figure 77. By Type, India Structural Heart Disease Intervention Devices Sales Volume Market Share, 2022 VS 2029
Figure 78. By Application, India Structural Heart Disease Intervention Devices Sales Volume Market Share, 2022 VS 2029
Figure 79. Middle East & Asia Structural Heart Disease Intervention Devices Sales Volume, 2018-2029, (K Units)
Figure 80. By Company, Middle East & Asia Structural Heart Disease Intervention Devices Market Share, 2022
Figure 81. By Type, Middle East & Asia Structural Heart Disease Intervention Devices Sales Volume Market Share, 2022 VS 2029
Figure 82. By Application, Middle East & Asia Structural Heart Disease Intervention Devices Sales Volume Market Share, 2022 VS 2029
Figure 83. Research Methodology
Figure 84. Breakdown of Primary Interviews
Figure 85. Bottom-up Approaches
Figure 86. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|